Poltreg S.A.
A clinical-stage biotech developing T-regulatory cell therapies for autoimmune diseases.
PTG | WAR
Overview
Corporate Details
- ISIN(s):
- PLPLTRG00012 (+2 more)
- LEI:
- 259400XSAJTERJ42VZ86
- Country:
- Poland
- Address:
- GDAŃSK BOTANICZNA 20, 80-298 GDAŃSK
- Website:
- https://poltreg.com/
Description
Poltreg S.A. is a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases. The company specializes in treatments based on T-regulatory cells (Tregs), with an advanced pipeline of both polyclonal and engineered cell therapies. Its lead product, PTG-007, is an autologous Treg treatment being investigated for Type 1 Diabetes and Multiple Sclerosis. Poltreg is also advancing next-generation engineered therapies, including Chimeric Antigen Receptor T-regulatory cells (CAR-Tregs), for neuroinflammatory conditions such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). The company operates its own state-of-the-art, cGMP-certified manufacturing facility to produce its advanced therapy medicinal products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-20 17:50 |
Sprawozdanie z badania
|
Polish | XHTML • 2.5 MB | ||
| 2023-04-20 17:50 |
Sprawozdanie z działalności
|
Polish | XML • 20.6 KB | ||
| 2023-04-20 17:50 |
Sprawozdanie z działalności
|
Polish | XHTML • 12.1 MB | ||
| 2023-04-20 17:50 |
Sprawozdanie Finansowe
|
Polish | XML • 40.2 KB | ||
| 2023-04-20 17:50 |
Sprawozdanie Finansowe
|
Polish | XHTML • 4.4 MB | ||
| 2023-04-20 17:50 |
List Prezesa Zarządu
|
Polish | XML • 20.7 KB | ||
| 2023-04-20 17:50 |
List Prezesa Zarządu
|
Polish | XHTML • 1.3 MB | ||
| 2023-03-17 21:59 |
Zmiana adresu siedziby PolTREG S.A. i adresu strony internetowej - Content (PL)
|
Polish | HTML • 845 bytes | ||
| 2023-03-16 12:12 |
Zawarcie z Clinmark sp. z o.o. zlecenia na prace przygotowawcze do rozpoczęcia …
|
Polish | HTML • 1.5 KB | ||
| 2023-03-15 18:31 |
Uzupełnienie informacji nt. nowego Członka Zarządu PolTREG S.A. - Content (PL)
|
Polish | HTML • 3.0 KB | ||
| 2023-03-14 20:16 |
Powołanie nowego Członka Zarządu PolTREG S.A. - Content (PL)
|
Polish | HTML • 853 bytes | ||
| 2023-02-13 15:02 |
Zawarcie z Clinmark sp. z o.o. zlecenia na przeprowadzenie badania klinicznego …
|
Polish | HTML • 2.1 KB | ||
| 2023-01-30 14:23 |
Harmonogram publikacji raportów okresowych w 2023 rokuHarmonogram publikacji ra…
|
Polish | HTML • 823 bytes | ||
| 2023-01-16 14:25 |
Zawarcie umowy z Agencją Badań Medycznych na realizację i dofinansowanie projek…
|
Polish | HTML • 2.4 KB | ||
| 2023-01-05 20:29 |
Zawiadomienie od TFI Allianz Polska S.A. o zmianie udziału w ogólnej liczbie gł…
|
Polish | HTML • 3.1 KB |
Automate Your Workflow. Get a real-time feed of all Poltreg S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Poltreg S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Poltreg S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
